Pregled bibliografske jedinice broj: 1133432
Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases
Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases // The Breast Journal, 26 (2020), 9; 1781-1783 doi:10.1111/tbj.13842 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 1133432 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Novel targetable biomarkers in clear cell
carcinoma of the breast uncovered by molecular
profiling: A study of nine cases
Autori
Skenderi, Faruk ; Palazzo, Juan ; Swensen, Jeffrey ; Feldman, Rebecca ; Contreras, Elma ; Florento, Elena ; Gatalica, Zoran ; Vranic, Semir
Izvornik
The Breast Journal (1075-122X) 26
(2020), 9;
1781-1783
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
breast cancer ; clear cell carcinoma ; immunotherapy ; molecular profiling ; targeted therapy
Sažetak
We profiled nine pure clear cell carcinomas of the breast using massively parallel DNA and RNA sequencing (NGS), in situ hybridization (ISH), and immunohistochemistry (IHC). All cases were primary mammary clear cell carcinomas that were diagnosed in female patients (mean age: 53.4 years ; range: 31-69 years). Based on our findings, we conclude that the majority of clear cell carcinomas are ER/PR positive and consequently amenable to anti-ER treatment modalities. A subset of clear cell carcinomas also harbored alterations in PIK3CA/PTEN/AKT pathway, particularly PTEN, indicating a potential benefit of PI3K/Akt/mTOR inhibitors. The status of I-O biomarkers in clear cell carcinomas indicates a limited therapeutic benefit of immune checkpoint inhibitors (against PD-1/PD-L1).
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE